SWS Partners’s Novartis NVS Stock Holding History

SWS Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-105	Closed	-$7K	–	240
2018 Q1	$7K	Hold	105	–	–	0.01%	286
2017 Q4	$8K	Buy	+105	New	+$7.92K	0.01%	277

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

SWS Partners's NVS Position: Q2 2018 in Review

SWS Partners sold out of Novartis (NVS) in Q2 2018, closing a stake of 105 shares — an estimated $7K sold.

SWS Partners first reported a position in NVS in Q4 2017 and held it in 2 quarters. The position peaked at $8K in Q4 2017. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

SWS Partners reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
SWS Partners sold 105 Novartis shares in Q2 2018, an estimated $7K.
SWS Partners first reported a position in Novartis in Q4 2017 and held it in 2 quarters.
SWS Partners's Novartis position peaked at $8K in Q4 2017.
987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on SWS Partners's 13F filing for Q2 2018, filed 13 Aug 2018.